Memorial Sloan Kettering Cancer Center

05/14/2026

Sundas was frying spring rolls for a dinner party when suddenly everything went dark. Fast forward to a few months later, Sundas was at MSK being treated for a lesion in her brain.

She met first with MSK neurosurgeon Dr. Vivian Tabar, and knew immediately that she had made the right decision. Dr. Tabar performed an awake craniotomy and was able to remove 95% of the tumor. Dr. Tabar told her the recovery could be difficult, but that the symptoms would improve with time. Six months later, Sundas was recovering well. Her speech was fluent, and her cognitive function was much improved though not fully back to normal.

Her tumor was identified as oligodendroglioma. Her MSK neuro-oncologist Dr. Ingo Mellinghoff presented her treatment options — standard radiation and chemotherapy on one hand or a clinical trial drug called vorasidenib on the other.

Sundas chose the clinical trial and has been on vorasidenib for nearly five years now, and her cancer has remained stable.

“This is a groundbreaking drug,” Sundas says. “We waited for so long for something like this to come to the market. I’m just thankful it’s there.”

Today, she has found meaning in ordinary joys like daily walks in the park, spending time with her two children and husband, as well as serving on a nonprofit dedicated to helping others with brain cancer.

Read more of Sundas' story:

https://bit.ly/4dH5JXr

05/12/2026

We recently celebrated Nurses Week at MSK the best way we know how: with a full breakfast spread and even fuller hearts. Thank you to everyone who joined us for our staff breakfasts across many of our regional sites.

05/12/2026

In honor of Nurses Week, we celebrate three generations of nurses at MSK: Nelly, Jennifer, and Mia. This grandmother, mother, and daughter trio have combined nursing careers at MSK that span nearly six decades.

For Mia, Nelly's granddaughter and Jennifer's daughter, nursing wasn't just a career path — it was a big part of her childhood.

"My mom would bring me to work with her when I was little," Mia recalls. "I was constantly surrounded by nurses and inspired by the work they do every day. I was fascinated by the professionalism and compassion of every nurse I met.”

Nelly, Jennifer, and Mia’s family legacy of nursing is built not just on clinical excellence, but on the wisdom passed down through dinner conversations and debriefing sessions, through a grandmother's garden and a mother's community service, through the simple act of showing up day after day and leading with empathy.

This Nurses Week, we celebrate Nelly, Jennifer, and Mia — three generations of nurses whose combined service represents the very best of what it means to be part of MSK. Their story reminds us that nursing is more than a profession: It's a calling that can inspire across generations, creating ripples of compassion that touch countless lives. 💙

05/11/2026

A special thank you to the American Nurses Association for visiting MSK during Nurses Week to celebrate our incredible nurses with coffee, swag, and appreciation for all that they do every day.

Swipe through for a look at the festivities. ➡️

05/06/2026

After surviving Hodgkin lymphoma as a teenager, MSK Nurse Joe Bacani now helps guide younger adults facing cancer, bringing both personal experience and compassion to his work. Read more about his story from Men's Health.

Joe Bacani knows exactly what young people with cancer are going through—because he lived it.

05/06/2026

05/06/2026

This Nurses Week, we asked MSK nurses across our New York City and regional sites to share their wishes for their colleagues.

From hoping colleagues feel they make a difference to dreaming of beach vacations, these messages show the heart and humor of our incredible nursing team.

What is one wish you have for an MSK nurse in your life? Let’s fill our comments with gratitude. ✨

05/04/2026

In 2018, Carly was 20 years old and about to start her senior year of college when she noticed that a mole on her lower back had changed.

A biopsy from her local dermatologist confirmed that Carly had melanoma.

“I had just moved into my apartment near Rutgers University and I was terrified,” Carly says. “My dad came and picked me up from school and I remember being unable to speak on the whole drive home.”

After meeting with doctors across the country, Carly chose to receive her care at MSK, where she began treatment with MSK melanoma oncologist Dr. Michael Postow. Over the next several years, her cancer returned and progressed, and she underwent multiple treatments, including targeted therapy, immunotherapy, surgeries, radiation, and a clinical trial.

In 2024, under the care of MSK melanoma medical oncologist Dr. James Smithy, Carly began tumor-infiltrating lymphocyte (TIL) therapy shortly after the treatment received FDA approval. This type of immunotherapy uses the body’s own cells to fight cancer and is a promising approach for some solid tumors, especially melanoma.

The TIL treatment helped shrink Carly’s melanoma significantly. To further manage her disease, she has continued targeted therapy for the past year and a half, with stable results. “I’m so happy I chose MSK and continue to feel confident in my care, with access to the latest research and treatment options and the kindness of every doctor, nurse, and staff member,” Carly says.

Now 28, Carly is back to many of the things she loves, including morning walks, time with friends and family, and finding joy in everyday moments.

When asked what she would tell someone who is newly diagnosed with cancer, Carly shares: “Thinking about right now and focusing on doing the best you can in each little moment feels more possible than trying to look at how far you still need to go. Also, having a support system that always makes sure to point out small victories continues to help me on my journey every day.”

Leave a 💛 in the comments below for Carly!

05/04/2026

🗓️ Save the date! NYC for MSK is back on Friday, May 29.

Every year, brands across New York City unite to honor the anniversary of Memorial Sloan Kettering Cancer Center (MSK). A few returning partners include FAO Schwarz, Yankees, Ralph Lauren, Roller Rabbit, Tanya Taylor, and more.

Get involved and learn more here: https://bit.ly/4tZk4V1

04/30/2026

April is Testicular Cancer Awareness Month, and MSK is at the forefront of treating this rare cancer.

As part of the program ranked No. 1 in the nation by U.S. News & World Report for three consecutive years, MSK’s multidisciplinary testicular cancer team sees approximately 5% of all te**is cancer diagnoses in the country, a remarkable figure given that only about 10,000 cases occur annually in the United States.

“Testis cancer is probably an underappreciated cancer relative to other malignancies given how rare it is,” says MSK urologic surgeon Dr. Richard Matulewicz. "It's most common in young men, but fortunately, it's highly curable, particularly when found early.”

Because te**is cancer patients are typically young, with decades of life ahead of them, MSK's team is thoughtful about treatment approaches.

“The field has started to look into modalities that reduce or avoid unnecessary treatment,” Dr. Matulewicz explains. “We're figuring out the best way to match someone's goals, comorbidities, age, and other aspects that influence management, recognizing that our goal remains not just cure, but quality of life.”

Learn more about testicular cancer and when to talk to your doctor: https://bit.ly/3QGFkjJ

Find up-to-date information about testicular cancer (germ cell tumors) and learn about risk factors for developing this disease.

04/30/2026

Memorial Sloan Kettering Cancer Center (MSK) congratulates Dr. Nicole B. Saphier on her nomination to become the next Surgeon General of the United States. Over her decade of service to the MSK community, Dr. Saphier has been a tireless advocate for women’s health and early cancer detection, expanding access to breast cancer screening, and raising awareness at a community and national level. We are grateful for her steadfast commitment to delivering excellent patient care and her willingness to serve our country in this capacity.